Loading insider details...
Beta
Latest Form 4 (Sep 30, 2026): Conversion of 10,690,530 ADRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | ADARx Pharmaceuticals, Inc. (ADRX) | Conversion | 10,690,530 | n/a |
| Sep 23, 2026 | Electra Therapeutics, Inc. (ETRA) | Conversion | 2,002,310 | n/a |
| Aug 12, 2026 | BlossomHill Therapeutics, Inc. (BLSM) | Conversion | 1,039,996 | n/a |
| Aug 11, 2026 | Braveheart Bio, Inc. (BRVE) | Conversion | 9,132,420 | n/a |
| Jul 29, 2026 | Scribe Therapeutics, Inc. (SCTX) | Conversion | 348,825 | n/a |
| Jul 9, 2026 | Sionna Therapeutics, Inc. (SION) | Sale | 85,918 | $3.85M |
| Jul 2, 2026 | Sionna Therapeutics, Inc. (SION) | Sale | 115,844 | $5.27M |
| Jun 24, 2026 | Enliven Therapeutics, Inc. (ELVN) | Sale | 24,846 | $1.13M |
| Jun 17, 2026 | Enliven Therapeutics, Inc. (ELVN) | Sale | 9,086 | $409.1K |
| Jun 15, 2026 | Shattuck Labs, Inc. (STTK) | Purchase | 1,041,667 | n/a |